Iguana Healthcare Management’s Celldex Therapeutics CLDX Stock Holding History

Iguana Healthcare Management’s Portfolio CLDX Stock Details CLDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-5,000	Closed	-$1.89M	–	76
2015 Q2	$1.89M	Sell	5,000 -1,667	-25%	-$662K	0.6%	47
2015 Q1	$2.79M	Hold	6,667	–	–	1.17%	31
2014 Q4	$1.82M	Sell	6,667 -3,333	-33%	-$829K	0.88%	40
2014 Q3	$1.94M	Sell	10,000 -4,000	-29%	-$872K	1.04%	37
2014 Q2	$3.43M	Sell	14,000 -333	-2%	-$75.2K	1.6%	25
2014 Q1	$3.8M	Buy	14,333 +1,000	+8%	+$383K	1.76%	18
2013 Q4	$4.84M	Buy	+13,333	New	+$5.14M	2.76%	10

Other funds holding CLDX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Iguana Healthcare Management's CLDX Position: Q3 2015 in Review

Iguana Healthcare Management sold out of Celldex Therapeutics (CLDX) in Q3 2015, closing a stake of 5,000 shares — an estimated $1.89M sold.

Iguana Healthcare Management first reported a position in CLDX in Q4 2013 and held it in 7 quarters. The position peaked at $4.84M in Q4 2013. 162 funds tracked by Wall St. Rank hold CLDX as of Q3 2015.

Iguana Healthcare Management reported no remaining Celldex Therapeutics position as of Q3 2015 after selling out during the quarter.
Iguana Healthcare Management sold 5,000 Celldex Therapeutics shares in Q3 2015, an estimated $1.89M.
Iguana Healthcare Management first reported a position in Celldex Therapeutics in Q4 2013 and held it in 7 quarters.
Iguana Healthcare Management's Celldex Therapeutics position peaked at $4.84M in Q4 2013.
162 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2015.

Based on Iguana Healthcare Management's 13F filing for Q3 2015, filed 16 Nov 2015.